Such cancer-enabling PPIs will become promising therapeutic targets in anticancer strategies as the technologies in PPI modulator discovery and validating agents in the clinical setting advance in the future [ 15].
After a general discussion about the pitfalls of validating agent-based models that simulate complex spatial systems, we briefly present a validation method based on role playing.
On the other hand, fine-grained behavioral information may be used to inform and validate agent-based models of nosocomial infection [21].
The methodology for this study comprises an empirically validated NETLOGO agent-based model of worker attrition using OPM data sets for high-density STEM organizations.
It should also be noted that some populations are more suited to treatment with a second-line therapy than with a first-line therapy, irrespective of how well validated each agent is, that is, a smaller evidence base does not necessarily mean that a treatment is inferior.
The need to validate therapeutic agents in clinical trials is a key challenge in drug development for arthritis [ 1].
The method was tested by carrying out an experimental role play to validate individual agent tasks, focusing on the ability of agents to generate beliefs and preferences about their environment.
In fact, whilst this rounding is validated for chemotherapy agents [ 21], and it has been recently suggested that biologic agents rounding would be the same [ 26].
For this reason, we decided to perform a direct comparison of a series of substrates and ABPs that have been independently validated as imaging agents for the cysteine cathepsins.
The compounds of this class of HDACis (class III) are much less validated as anticancer agents compared to HDAC I and II.
We are currently validating this agent in animal models of chemical-induced ALI and testing its efficacy in reducing ALI caused by other agents such as influenza and smoke inhalation.
